Wound Care
Engineered for Rapid and Consistent Preparation,
at Point of Care, using Regen® Innovative Methods.
Autologous Cellular Preparations and A-PRP®
Regenlab® USA
Regen Lab is a leading innovator of medical device in the field of products intended for autologous regenerative medicine, based on an extemporaneous preparation of Platelet-Rich Plasma (PRP, autologous thrombin…) from the patient’s blood, cell therapy (in particular extract MSCs from bone marrow) and combined therapy (PRP combined with hyaluronic acid).
To date, Regen Lab’s patented technologies are available in over 160 countries worldwide, and have been used to treat over 2 million patients in various therapeutic areas (musculoskeletal, dermal, wound care and intimacy)leading to the publication of over 120 research projects.
The RegenLab® difference: Your advantages at a glance
![]()
Technological benefits
- Standardized preparation
- Minimum Blood Requirements
- Closed-Loop System: maximized safety
- Stable Physical Separation
- Reversible, Pharmaceutical-Grade Anticoagulation
- pH Neutral Anticoagulant for Patient Tolerability
- Rapid Centrifugation: 5 minutes
- Ease of Preparation: efficient & reproducible
- Facilitates and streamlines routine practice

Biological benefits
- Standardized, Leukocyte-Poor, and Consistent
- Platelet Recovery >80%
- High Platelet Quality: viability & functionality
- Full Plasma Recovery: maximized Growth factor and fibrinogen content
- Maximized Purity: >99.7% RBC depletion
- Extreme Cellular Selectivity: ~96.5% GRN & 70-80% MNC elimination
![]()
Scientific benefits
- Demonstrated safety and efficacy
- Evidence-based outcomes for numerous therapeutic indications
- Large number of clinical studies, with over 200 publications

